JP2001527517A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001527517A5 JP2001527517A5 JP1998508931A JP50893198A JP2001527517A5 JP 2001527517 A5 JP2001527517 A5 JP 2001527517A5 JP 1998508931 A JP1998508931 A JP 1998508931A JP 50893198 A JP50893198 A JP 50893198A JP 2001527517 A5 JP2001527517 A5 JP 2001527517A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/687,671 US6197743B1 (en) | 1996-07-26 | 1996-07-26 | Compositions and methods for the treatment of viral disorders |
| US08/687,671 | 1996-07-26 | ||
| US08/687,670 US5939456A (en) | 1996-07-26 | 1996-07-26 | Pulsed administration of compositions for the treatment of blood disorders |
| US08/687,670 | 1996-07-26 | ||
| PCT/US1997/012818 WO1998004290A2 (en) | 1996-07-26 | 1997-07-28 | Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001527517A JP2001527517A (ja) | 2001-12-25 |
| JP2001527517A5 true JP2001527517A5 (https=) | 2005-04-07 |
Family
ID=27104047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50893198A Pending JP2001527517A (ja) | 1996-07-26 | 1997-07-28 | 血液、ウイルス性および細胞性疾患の治療組成物 |
Country Status (5)
| Country | Link |
|---|---|
| EP (4) | EP1886677A1 (https=) |
| JP (1) | JP2001527517A (https=) |
| AU (1) | AU3889197A (https=) |
| CA (1) | CA2263675C (https=) |
| WO (1) | WO1998004290A2 (https=) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910624B1 (en) | 1995-03-03 | 2011-03-22 | The Trustees Of Boston University | Compositions for the treatment of blood disorders |
| AU774861B2 (en) | 1998-02-11 | 2004-07-08 | Douglas V Faller | Compositions and methods for the treatment of cystic fibrosis |
| AU2685399A (en) * | 1998-03-26 | 1999-10-18 | Julianna Lisziewicz | Method of rendering a human immunodeficiency virus population replication incompetent (in vivo) |
| DE19839566C2 (de) * | 1998-08-31 | 2002-01-17 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten in der Transplantationsmedizin |
| DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| KR100788970B1 (ko) * | 1999-11-05 | 2007-12-27 | 에미스페어 테크놀로지스, 인코포레이티드 | 활성제 전달용 페녹시 카르복시산 화합물 및 조성물 |
| DE10000577A1 (de) | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| GB0008966D0 (en) | 2000-04-13 | 2000-05-31 | Imp College Innovations Ltd | Vectors for gene therapy |
| WO2001082927A1 (en) * | 2000-05-02 | 2001-11-08 | Lead Chemical Co., Ltd | Antibiral compositions containing phorbol derivatives as the main active ingredient |
| HU230252B1 (hu) | 2001-01-12 | 2015-11-30 | Biogen Idec International Gmbh | Fumársav-amid származékok |
| DE10101307A1 (de) * | 2001-01-12 | 2002-08-01 | Fumapharm Ag Muri | Fumarsäurederivate als NF-kappaB-Inhibitor |
| SI1663197T1 (sl) | 2003-09-09 | 2008-06-30 | Biogen Idec Internat Gmbh | Uporaba derivatov fumarne kisline za zdravljenje sräśne insuficience in astme |
| GB0413702D0 (en) | 2004-06-18 | 2004-07-21 | Molmed Spa | Thymidine kinase |
| LT2801354T (lt) | 2004-10-08 | 2017-06-26 | Forward Pharma A/S | Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį |
| EP1915334A2 (en) * | 2005-07-07 | 2008-04-30 | Aditech Pharma AB | Novel salts of fumaric acid monoalkylesters and their pharmaceutical use |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| EP2046736B1 (en) * | 2006-07-27 | 2019-06-12 | Emisphere Technologies, Inc. | Arylsulfanyl compounds and compositions for delivering active agents |
| AR064777A1 (es) | 2007-01-10 | 2009-04-22 | Inst Di Reserche D Biolog Mole | Indazoles sustituidos con amida como inhibidores de poli (adp- ribosa) polimerasa (parp) |
| EP2680006A1 (en) | 2007-02-08 | 2014-01-01 | Biogen Idec MA Inc. | Treatment for Amyotrophic Lateral Sclerosis |
| JP5031778B2 (ja) * | 2007-02-14 | 2012-09-26 | 株式会社カネカ | 光学活性な２−（アロイルオキシ）プロピオン酸を用いたアミン化合物の製造方法 |
| WO2008128299A1 (en) * | 2007-04-24 | 2008-10-30 | Murdoch Childrens Research Institute | Therapeutic protocol for treating hemoglobinopathy |
| CN101959429B (zh) | 2008-01-08 | 2014-09-10 | 阿克塞利亚制药公司 | 抗微生物肽系统的激动剂 |
| EP2276478A4 (en) * | 2008-04-11 | 2012-03-07 | Aids Res Alliance | METHOD FOR THE ADMINISTRATION OF PROSTRATIN AND STRUCTURAL ANALOGUE THEREOF |
| WO2010079222A1 (en) | 2009-01-09 | 2010-07-15 | Forward Pharma A/S | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
| US20110086869A1 (en) | 2009-09-24 | 2011-04-14 | The Trustees Of Boston University | Methods for treating viral disorders |
| WO2011072086A1 (en) * | 2009-12-08 | 2011-06-16 | Hemaquest Pharmaceuticals, Inc. | Methods and low dose regimens for treating red blood cell disorders |
| US20110245154A1 (en) * | 2010-03-11 | 2011-10-06 | Hemaquest Pharmaceuticals, Inc. | Methods and Compositions for Treating Viral or Virally-Induced Conditions |
| JP2013523795A (ja) | 2010-04-06 | 2013-06-17 | バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー | 植物のストレス耐性を増強させるための４−フェニル酪酸及び／又はその塩の使用 |
| KR101293620B1 (ko) | 2011-08-19 | 2013-08-13 | 국립암센터 | 트랜스-스플라이싱 라이보자임 및 암치료 유전자를 포함하는 재조합 아데노바이러스 및 이의 용도 |
| BR112015022854A2 (pt) | 2013-03-14 | 2017-07-18 | Alkermes Pharma Ireland Ltd | pró-farmacos de fumaratos e uso do mesmo no tratamento de várias doenças |
| US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| JP6337135B2 (ja) | 2014-02-24 | 2018-06-06 | アルカーメス ファーマ アイルランド リミテッド | フマル酸エステルのスルホンアミドプロドラッグ及びスルフィンアミドプロドラッグ並びに種々の疾患の治療におけるその使用 |
| GB2567093A (en) | 2016-07-15 | 2019-04-03 | Viracta Therapeutics Inc | Histone deacetylase inhibitors for use in immunotherapy |
| WO2018140934A1 (en) * | 2017-01-30 | 2018-08-02 | The Children's Hospital Of Philadelphia | Compositions and methods for hemoglobin production |
| US12419884B2 (en) | 2018-08-06 | 2025-09-23 | Brigham Young University | Compositions and methods for treating iron overload |
| EP3930757A1 (en) | 2019-03-01 | 2022-01-05 | President And Fellows Of Harvard College | Methods and compositions for protein delivery |
| EP3937922A4 (en) * | 2019-03-14 | 2022-11-30 | Hemoshear Therapeutics, Inc. | Methods of treating organic acidemias |
| CA3142142A1 (en) | 2019-05-31 | 2020-12-03 | Viracta Subsidiary, Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
| AU2021336289A1 (en) * | 2020-09-01 | 2023-05-04 | I2O Therapeutics, Inc. | Ionic liquid formulations for treating diabetes |
| CN113621577B (zh) * | 2021-08-05 | 2023-03-10 | 河南普诺易生物制品研究院有限公司 | 人源化hek293细胞系表达重组蛋白用培养基添加剂、重组乙肝疫苗、表达方法 |
| EP4429704A4 (en) | 2021-11-10 | 2025-11-05 | I2O Therapeutics Inc | IONIC LIQUID COMPOSITIONS |
| CN120241679B (zh) * | 2025-03-06 | 2025-12-05 | 华南农业大学 | 方酸类化合物在制备抗弓形虫病药物中的应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US496525A (en) | 1893-05-02 | Eugene gillet de montmore | ||
| US4470970A (en) * | 1981-07-02 | 1984-09-11 | Burzynski Stanislaw R | Purified antineoplaston fractions and methods of treating neoplastic disease |
| FR2508797B1 (fr) * | 1981-07-03 | 1986-03-14 | Charles Chany | Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique |
| US4704402A (en) | 1982-06-12 | 1987-11-03 | University Of Pittsburgh | Method of treating sickle cell anemia |
| US4747825A (en) | 1984-06-29 | 1988-05-31 | Ferring Laboratories, Inc. | Apparatus and methodology for pulsed administration of growth promoting agents |
| US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
| US4948592A (en) | 1986-05-09 | 1990-08-14 | Alza Corporation | Pulsed drug delivery |
| US4723958A (en) | 1986-05-23 | 1988-02-09 | Merck & Co., Inc. | Pulsatile drug delivery system |
| US5025029A (en) | 1986-10-10 | 1991-06-18 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin |
| US4822821A (en) | 1986-10-10 | 1989-04-18 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin |
| US4965251A (en) | 1987-04-03 | 1990-10-23 | The Board Of Regents Of The University Of Washington | Pulse treatment of hemoglobinopathies with erythropoietin |
| US5032507A (en) | 1987-11-13 | 1991-07-16 | The Salk Institute For Biological Studies | Potentiation of erythropoiesis |
| ES2061963T3 (es) * | 1988-01-13 | 1994-12-16 | Univ Arizona State | Briostatinas inmunomoduladoras. |
| US4997815A (en) | 1988-11-01 | 1991-03-05 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin |
| CA2038945A1 (en) * | 1989-08-01 | 1991-02-02 | Norman D. Weiner | Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes |
| EP0546261A3 (en) * | 1991-09-12 | 1993-08-11 | American Cyanamid Company | Method of treating latent herpes viral infections |
| US5605930A (en) * | 1991-10-21 | 1997-02-25 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
| EP0567613B1 (en) * | 1991-10-21 | 2002-02-20 | The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Compositions for therapy and prevention of cancer |
| US5403590A (en) | 1992-12-21 | 1995-04-04 | New England Deaconess Hospital Corporation | Method of pulsatile drug infusion |
| WO1995011699A1 (en) * | 1993-10-29 | 1995-05-04 | The Trustees Of Boston University | Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| IL110380A0 (en) * | 1994-07-20 | 1994-10-21 | Agis Ind 1983 Ltd | Antiviral topical pharmaceutical compositions |
| US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
-
1997
- 1997-07-28 EP EP07014281A patent/EP1886677A1/en not_active Withdrawn
- 1997-07-28 EP EP97936153A patent/EP0969869A2/en not_active Ceased
- 1997-07-28 EP EP10184726A patent/EP2298350A3/en not_active Withdrawn
- 1997-07-28 AU AU38891/97A patent/AU3889197A/en not_active Abandoned
- 1997-07-28 CA CA2263675A patent/CA2263675C/en not_active Expired - Fee Related
- 1997-07-28 EP EP05012584A patent/EP1611885A1/en not_active Withdrawn
- 1997-07-28 WO PCT/US1997/012818 patent/WO1998004290A2/en not_active Ceased
- 1997-07-28 JP JP50893198A patent/JP2001527517A/ja active Pending